New Technique Allows Researchers to Custom 3D Print Bacteria-Resistant Medical Devices

IMTS

Share this Article

A team of engineers and health experts led by mechanics professor Ricky Wildman from the University of Nottingham, UK, found a new way to design and manufacture custom medical devices to boost performance and bacterial resistance. Using a combination of multi-material inkjet 3D printing and genetic algorithms, the researchers designed tailored composite artificial body parts and other medical devices with built-in functionality that offer better shape and durability while cutting the risk of bacterial infection at the same time. The study opens the possibility of a new manufacturing concept to produce devices with spatially distributed, customizable material functionalities in a cost-effective manner.

Medical device-associated infections, such as those on implanted prostheses, can easily become contaminated with bacteria and often result in poor clinical outcomes. This has led to major challenges in treating bacterial biofilm, which have numerous harmful effects. Biofilms are communities of bacteria isolated within a self-produced extracellular matrix that achieves up to 1,000 times greater tolerance to antibiotics, host immune system defenses. They are a major unsolved global biomedical problem that accounts for 25.6% of all healthcare-associated infections within the U.S. alone.

According to experts, there are major challenges in treating biofilms, such as difficult diagnosis, and in the clinic, biofilms can also be hard to eradicate due to their high tolerance to antibiotics, which are widely used to reduce device infections but are often accompanied by localized toxicity, and other side effects. There have been several approaches to reducing the adhesion of bacteria on medical devices, including antibacterial medication coatings in 3D printable polymers.

Inspired by the need to address device associated bacterial infections and antimicrobial resistance, the novel process proposed by the researchers and published in the journal Advanced Science proposes using a computer-aided, multi-material 3D printing technique that demonstrates it is possible to combine complex functions within one customized healthcare device to enhance patient wellbeing. According to the study’s lead author and Transitional Assistant Professor at the University of Nottingham’s Faculty of Engineering Yinfeng He, most mass-produced medical devices fail to meet their users’ unique and complex needs completely. At the same time, single-material 3D printing methods have design limitations that cannot produce a bespoke device with multiple biological or mechanical functions.

Aging populations worldwide, rising cases of chronic disease, and global health crisis are leading to a natural and increasing demand for medical devices, where 3D printing has turned into an ally thanks to its cost-effectiveness compared to conventional manufacturing techniques. 3D printed medical devices are cheaper and can be tailored and more easily replaced when parts are damaged and as children grow. Moreover, with the new technique from the University of Nottingham researchers, the healthcare field could further improve patients’ lives and ease the financial burden on growing government health budgets.

The schematic approach of the methodology followed to develop, 3D print, and characterize bespoke biofilm inhibiting devices. Image courtesy of University of Nottingham.

The study authors hope that the innovative design process can be applied to 3D print any medical device that needs customizable shapes and functions. For example, the method could be adapted to create a highly-bespoke one-piece prosthetic limb or joint to replace a lost finger or leg that can fit the patient perfectly to improve their comfort and the prosthetic’s durability. Alternatively, it could be used to print customized pills containing multiple drugs – known as polypills – optimized to release into the body in a pre-designed therapeutic sequence.

For this study, the researchers applied a computer algorithm to design and manufacture – pixel by pixel – 3D printed objects made up of two polymer materials of differing stiffness that also prevent the build-up of bacterial biofilm. They successfully achieved custom-shaped and -sized parts that offer the required flexibility and strength by optimizing the stiffness.

Through multi-material inkjet 3D printing, via a dual-head PiXDRO LP50 inkjet printer from SUSS MicroTec, they were able to engineer the ratio of different inks in each voxel to exhibit the required performance, such as modulus or transparency. They used both inkjet printable biofilm-resistant formulations and a computational design approach to direct the manufacture of multi-material devices. As part of the study, the team was able to 3D print a finger joint with the traditional functionality of artificial finger joint replacements that are also rigid enough to implant into the bone. Additionally, they customized its size and strength to meet individual patient requirements.

A bacteria-repelling artificial finger joint prosthetic with customized strength distribution made with the multi-material 3D print process. Image courtesy of the University of Nottingham.

With an added level of design control, the team performed their new style of 3D printing with multi-materials that are intrinsically bacteria-resistant and bio-functional, allowing them to be implanted and combat infection (which can occur during and after surgery) without the use of added antibiotic drugs. They also adopted a new high-resolution characterization technique from German electronics manufacturer IONTOF. The 3D orbiSIMS instrument was used to 3D-map the chemistry of the print structures and to test the bonding between them throughout the part. This identified that – at very small scales – the two materials were intermingling at their interfaces, a sign of good bonding which means a better device is less likely to break.

Today, a few antibacterial polymers are available on the market. Still, techniques to 3D print bacterial biofilm-resistant products are lacking, and prevention of bacterial biofilm formation at the surfaces of medical devices is critical. This study carried out by the University of Nottingham’s Centre for Additive Manufacturing (CfAM) and funded by the UK’s Engineering and Physical Sciences Research Council allow the design and manufacture of highly personalized devices that avoid biofilm formation and, more importantly, do not contribute to antimicrobial resistance. Before commercializing the technique, the researchers plan to broaden its potential uses by testing it on more advanced materials with extra functionalities such as controlling immune responses and promoting stem cell attachment.

Share this Article


Recent News

Interview: Rethinking 3D Printing for High-Volume Production with Exentis

3D Printing Financials: Prodways’ Q1 2024 Revenue Drop and Accounting Overhaul



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3D Printing Financials: Fathom Struggles in Financial Quicksand During Critical Transition

Facing a year of key transitions and financial pressures, Fathom (Nasdaq: FTHM) has filed its annual report for 2023 with the U.S. Securities and Exchange Commission (SEC). The document outlines...

Latest Earnings Overview for Australian 3D Printing Firms Titomic and AML3D

Australian 3D printing manufacturing firms Titomic (ASX: TTT) and AML3D (ASX: AL3) reported their financial results for the period from July to December 2023, marking the first half of their...

3D Printing Webinar and Event Roundup: April 7, 2024

Webinars and events in the 3D printing industry are picking back up this week! Sea-Air-Space is coming to Maryland, and SAE International is sponsoring a 3D Systems webinar about 3D...

3D Printing Financials: Unpacking Farsoon and BLT’s 2023 Performance

In the Chinese 3D printing industry, two companies, Farsoon (SHA: 688433) and Bright Laser Technologies, or BLT (SHA: 688333), have recently unveiled their full-year earnings for 2023. Farsoon reported increases...